N-(4-Chlorophenyl)phthalimide
CAS: 7386-21-2
Rif. 3D-HAA38621
1g | Fuori produzione | ||
5g | Fuori produzione | ||
10g | Fuori produzione | ||
25g | Fuori produzione | ||
50g | Fuori produzione | ||
100g | Fuori produzione | ||
100mg | Fuori produzione |
Informazioni sul prodotto
- 1H-Isoindole-1,3(2H)-dione, 2-(4-chlorophenyl)-
- 2-(4-Chlorophenyl)-2,3-dihydro-1H-isoindole-1,3-dione
- 2-(4-Chlorophenyl)isoindole-1,3-dione
- 2-(4-Chlorophenyl)isoindoline-1,3-dione
- 2-(4-chlorophenyl)-1H-isoindole-1,3(2H)-dione
- Ai3-01392
- Brn 0189458
- N-(p-Chlorophenyl)phthalimide
- Nsc 406154
- Phthalimide, N-(p-chlorophenyl)-
- Vedi altri sinonimi
- 5-21-10-00293 (Beilstein Handbook Reference)
N-(4-Chlorophenyl)phthalimide is a chiral compound that has been studied for its potential use as a cholesterol-lowering drug. This drug has been shown to inhibit the synthesis of cholesterol in the liver and other tissues. N-(4-Chlorophenyl)phthalimide has also been shown to inhibit epileptic seizures in rats, with an effective dose of 10 mg/kg. The primary mechanism by which this drug works is not known, but it may be due to its ability to increase levels of the neurotransmitter γ-aminobutyric acid (GABA). This activity may be due to inhibition of GABA transaminase, which converts GABA into succinic semialdehyde.